Evidence map›Paper›PMID 42583820›Full record

ArticleNMR in biomedicine2026

Serum Metabolomic Profiling for Acute Myocardial Infarction Based on Nuclear Magnetic Resonance Spectroscopy.

Bing He, Zhengyi Sun, Chunyu Wang, Yiting Wang, Xuewen Li, Qi Zhou, Zhiguo Zhang, Jiancheng Xu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in NMR in biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bing HeDepartment of Laboratory Medicine, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, China.
Zhengyi SunDepartment of Laboratory Medicine, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, China.
Chunyu WangState Key Laboratory of Supramolecular Structure and Material, Jilin University, Changchun, China.
Yiting WangDepartment of Laboratory Medicine, Second Hospital of Jilin University, Changchun, China.
Xuewen LiDepartment of Hematology, The First Hospital of Jilin University, Changchun, China.
Qi ZhouDepartment of Pediatrics, The First Hospital of Jilin University, Changchun, China.
Zhiguo ZhangDepartment of Cardiology, The First Hospital of Jilin University, Changchun, China.ORCID https://orcid.org/0000-0002-4501-6423
Jiancheng XuDepartment of Laboratory Medicine, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, China.ORCID https://orcid.org/0000-0001-8796-271X

Funding

Project of the Jilin Science and Technology Development Program 20220401085YY
6 · The paper itself

Abstract

Acute myocardial infarction (AMI) is a leading cause of mortality and morbidity worldwide, and early accurate diagnosis is critical for improving patient prognosis. Current clinical diagnostic methods have inherent limitations and delays, creating an urgent need for reliable novel biomarkers. This study aims to identify differential biomarkers between AMI patients and healthy controls using nuclear magnetic resonance (

Indexed as

MetabolomeMetabolomicsMyocardial InfarctionAgedBiomarkersCase-Control StudiesFemaleHumansMagnetic Resonance SpectroscopyMaleMiddle AgedMultivariate AnalysisROC CurveBiomarkersacute myocardial infarctionmetabolic biomarkersmetabolomicsNMR

Identifiers

PMID42583820
PMCPMC13463286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.